Use of a 5HT2A and 5HT2A/C receptor antagonist for treating snoring and high resistance syndrome of upper anatomical airways
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 10, 2003
Grant Date -
N/A
app pub date -
Jun 19, 2001
filing date -
Dec 22, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The invention relates to the use of 5HT.sub.2A AND 5HT.sub.2A/C receptor antagonists for the treatment of snoring and upper airway high resistance syndrome.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully